✦ LIBER ✦

Response Assessments in Low-Risk and High-Risk Myelodysplastic Syndromes (MDS)

✍ Scribed by Pierre Fenaux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survivin expression in “low-risk” and “h

✍ Umberto Gianelli; Nicola Stefano Fracchiolla; Agostino Cortelezzi; Caterina Pell 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 166 KB

The challenge of individualised risk ass

✍ Reinhard Stauder 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 398 KB

Treatment with alpha-lymphoblastoid inte

✍ M.C. Petti; R. Latagliata; M.A. Aloe Spiriti; G. Avvisati; C. DeGregoris; P. Pon 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB

P-288 Azacitidine therapy in high-risk m

✍ Improta, S.; Gagliardi, A.; Villa, M.R.; Cioppa, P. Della; Esposito, M.; Izzo, G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

163 Amifostine in low-risk and combined

✍ O. Sezer; M. Stefanic; G. Dingeldein; H.-G. Mergenthaler; K. Possinger 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Current treatment strategies in low-risk

✍ Aristoteles A.N. Giagounidis; Ulrich Germing; Carlo Aul 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 144 KB